Go to main content
Slovakia
AOP Orphan is now AOP Health
NEWS

AOP Orphan is now AOP Health

READ MORE
PULMONARY ARTERIAL HYPERTENSION

"The time taken to establish the correct diagnosis is on average about 14 months."

HematoOncology

"I have two little children and they deserve a good life and a caring mother. That thought gives me strength."

Critical CARE

"We really wish COVID-19 patients would come to the hospital sooner."

Science & Innovation
From the Concept to the Drug

AOP Health team covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.

More on the global website
CONNECTED WORLDWIDE
Partnering

Partnering is of key importance for AOP Health. It allows further developing AOP Health’s rare disease and critical care portfolio and enables to approach patients beyond company’s core markets in Europe.

More on the global website
Join Us
Join AOP Health

AOP Health team develops and investigates therapy options for patients with rare diseases and in critical conditions – commitment and appreciation are the essence of our cooperative work.

More on the global website